FREE Subscription!
Enter your email address to subscribe to RxTrace and receive FREE notifications of new posts by email. (About one per week on Mondays)

Preview | Powered by FeedBlitz
RxTrace Recommends


Earlier Poplular Posts
  • 2015 (21)
  • 2014 (73)
  • 2013 (83)
  • 2012 (60)
  • 2011 (25)
  • 2010 (31)
  • 2009 (19)

U.S. Senate Passes H.R. 3204 With A Voice Vote

flag-usThe U.S. Senate has passed H.R. 3204, the Drug Quality and Security Act (DQSA) with a voice vote, sending the important legislation to the desk of President Barack Obama.  The President is expected to sign it happily.  In an email to members, John M. Gray, President and CEO of the Healthcare Distribution Management Association (HDMA) stated:

“Today the U.S. Senate passed the Drug Quality and Security Act (H.R. 3204). We expect it will be quickly signed into law by the President. This is the culmination of nearly 10 years of effort by HDMA members to preempt all state laws relating to drug pedigrees and track-and-trace systems, to further enhance the security and safety of our nation’s drug supply chain. Since 2004, HDMA has spearheaded industry efforts to preempt multiple and conflicting state laws related to pedigree and the traceability of drugs. …”

See the related press release here.

I also expect President Obama to sign the bill into law.  As I said in my essay earlier today (see “All Eyes On The U.S. Senate Tonight”), I will begin work on adding a banner to the top of all obsolete RxTrace essays and I will begin writing about the implications of the new prospective law.  Clients of Dirk Rodgers Consulting, LLC are welcome to contact me to schedule conference calls to discuss the implications to your projects and your businesses going forward.  All projects should be re-evaluated in light of this major action.


Related Posts Plugin for WordPress, Blogger...
Print Friendly

2 Responses to “U.S. Senate Passes H.R. 3204 With A Voice Vote”

  • Frank G says:


    Ok once President Obama signs this it supersedes all state requirements and it is my understanding we would no longer have to summit E pedigrees to Florida at that time at least until Jan. 1 2015. Do you know how this effects the reporting of the sale of controlled substances to Florida and other state that have that requirement today.

    • Dirk A. Rodgers says:

      Frank G,
      I am not aware that the DQSA would have any affect on the reporting of sales of controlled substances in Florida or any other state.

RxTrace Recommends


2015 Report ad.300x480

DSCSA Explained sidebar ad

About The Author
Dirk Rodgers

Dirk is an independent consultant and founder of RxTrace. He has contributed to many of the industry groups that have been formed over the last 10 years to investigate solutions to the problem of counterfeit and other illegitimate drugs in the legitimate supply chain. He served as co-chair of a number of key technical work groups in GS1 and GS1 US. These include the original GS1 EPCglobal Drug Pedigree Messaging work group that created the DPMS pedigree standard, the Network Centric ePedigree (NCeP) work group and the RFID Barcode Interoperability Guideline work group. Dirk holds a BS in Electrical and Computer Engineering from the University of Wisconsin-Madison.

View the Dirk Rodgers Consulting, LLC website

View Dirk's LinkedIn Profile

Follow Dirk on Twitter

RxTrace Testimonials
Easy to understand summary and discussion of complex current topics.
Dirk’s Latest Tweets @RxTrace
RxTrace Logo
RxTrace is a registered trademark of Dirk Rodgers Consulting, LLC. All rights reserved.